Patient deaths in a narcotic antagonist (naltrexone) and l-alpha-acetylmethadol program.
D000328:Adult; D006556:Heroin Dependence / Q000401:mortality / Q000534:rehabilitation; D006708:Homicide; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D008692:Methadyl Acetate / Q000627:therapeutic use; D009270:Naloxone / Q000031:analogs & derivatives*; D009271:Naltrexone / Q000627:therapeutic use*; D011619:Psychotropic Drugs / Q000506:poisoning; D019966:Substance-Related Disorders / Q000401:mortality; D013405:Suicide
D011619:Psychotropic Drugs; D009270:Naloxone; D009271:Naltrexone; D008692:Methadyl Acetate; D008691:Methadone